Heliospectra AB is pleased to announce that Dr. Suzanne Sisley will be presenting at the upcoming National Cannabis Summit and Heliospectra will be exhibiting in Booth #123. The event will take place on November 12-13 at the Sheraton Denver Downtown, Denver, Colorado.
Dr. Suzanne Sisley, M.D. Director of Medical Plant Research at Heliospectra, will be speaking on Monday, November 12 at 4:00 pm on the topic “Barriers of Marijuana Research / Veterans PTSD Cannabis Study”.
Dr. Sisley practices medicine in Scottsdale, AZ and specializes in Internal Medicine and Psychiatry. She is widely known for her research into potential medical uses of marijuana to treat veterans diagnosed with Post-Traumatic Stress Disorder - PTSD. Dr. Sisley’s research is supported by the Multidisciplinary Association for Psychedelic Studies (MAPS), a California-based nonprofit organization. In February this year Dr. Sisley was also appointed Director of Medicinal Plant Research at Heliospectra AB. Where her groundbreaking research will help customers understand what chemical profiles a medicinal plant therapy should express, and how to develop scalable medicinal plant growing methodologies.
The National Cannabis Summit is set on taking cannabis conferences to a new level by setting the future standard of cannabis business conferences. For this to happen MJ Conferences, an event management company, has paired together with Weedstock and Tribal Hemp & Cannabis Education. The event will feature a diverse series of panels, forums and speakers from three key parts of the cannabis industry; Business, Investor and Native American Involvement.
For further information regarding this event, please click on the following link: http://www.nationalcannabissummit.com/
For more information
Heliospectra AB
Staffan Hillberg, CEO
T: +46-708-36 59 44
Viridian Capital Advisors, LLC
Michael Swartz, Senior Analyst
T: 212-333-0257
